Did you know? Biocept initiated a clinical trial, the FORESEE Study, for patients with breast or non-small cell lung cancer (NSCLC) who have suspected or confirmed leptomeningeal metastases (LM).
Learn more: biocept.com/clinical-trials/
#CNSide #GetCancerAnswers #FORESEEStudy
1
2